Coagulation Factor IX API Manufacturers

compare suppliers & get competitive offers

teaser-1024x654-1
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Coagulation Factor IX is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Coagulation Factor IX or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Coagulation Factor IX API 181054-95-5?

Description:
Here you will find a list of producers, manufacturers and distributors of Coagulation Factor IX. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Coagulation Factor IX 
Synonyms:
Coagulation factor IX (recombinant) , Coagulation factor IX human , Coagulation factor IX recombinant human , Factor IX , recombinant , Factor IX , recombinant , Nonacog alfa  
Cas Number:
181054-95-5 
DrugBank number:
DB00100 
Unique Ingredient Identifier:
382L14738L

About Coagulation Factor IX

It's time for some technical information for the ones who understand chemistry: Recombinant Coagulation Factor IX is a purified Factor IX glycoprotein produced by recombinant DNA technology. It has a primary amino acid sequence that is identical to the Ala148 allelic form of human factor IX, and has structural and functional characteristics similar to those of endogenous factor IX. It is not derived from human blood (unlike human Factor IX complex), and is instead produced by a genetically engineered Chinese hamster ovary (CHO) cell line that secretes recombinant Factor IX into cell medium that is then processed and purified for use as a pharmaceutical agent. Recombinant Factor IX is indicated for the control and prevention of bleeding episodes in adult and pediatric patients with congenital factor IX deficiency (Hemophilia B).

You can ask the supplier about all relevant certificates for the product such as CoA, Safety Data Sheet and DMF.